drugset / Trial / NCT00650052
Fasting Study of Zonisamide Capsules 100 mg and Zonegran® Capsules 100 mg
RandomizedParallel-groupOpen-labelOther
Summary
The objective of this study was to investigate the bioequivalence of Mylan's zonisamide, 100 mg capsules to Elan's Zonegran® 100 mg capsules following a single, oral 100 mg (1 x 100 mg) dose administered under fasting conditions.
Timeline
- Start
- 2003-11
- Primary completion
- 2003-12
- Completion
- 2003-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zonisamide | Other / unclassified | 100 mg | Oral |
Indications
No indication recorded.